BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9267247)

  • 1. Theoretical and empirical arguments in relation to elective lymph node dissection for melanoma.
    Piepkorn M; Weinstock MA; Barnhill RL
    Arch Dermatol; 1997 Aug; 133(8):995-1002. PubMed ID: 9267247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
    Cole DJ; Baron PL
    Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized adjuvant therapy trials in melanoma: surgical and systemic.
    Eggermont AM; Gore M
    Semin Oncol; 2007 Dec; 34(6):509-15. PubMed ID: 18083374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in patients with melanoma.
    Thomas JM
    J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):442-6. PubMed ID: 19246272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current surgical treatment of primary malignant melanoma of the skin.
    Bognár J; Nagy P; Kádár E; Bajtai A; Mayer A; Daróczy J; Jakab F
    Acta Chir Hung; 1997; 36(1-4):37-8. PubMed ID: 9408278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous melanoma: therapeutic lymph node and elective lymph node dissections, lymphatic mapping, and sentinel lymph node biopsy.
    Pharis DB
    Dermatol Ther; 2005; 18(6):397-406. PubMed ID: 16297015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inguinal and pelvic lymph node dissection for stage III melanoma.
    Hughes TM; Thomas JM
    Br J Surg; 1999 Dec; 86(12):1493-8. PubMed ID: 10594495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.
    Bilchik AJ; Giuliano A; Essner R; Bostick P; Kelemen P; Foshag LJ; Sostrin S; Turner RR; Morton DL
    Cancer J Sci Am; 1998; 4(6):351-8. PubMed ID: 9853133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
    Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary treatment of primary melanoma.
    Yao K; Balch G; Winchester DJ
    Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of melanoma: benefits of surgical staging and adjuvant therapy.
    McMasters KM; Swetter SM
    J Surg Oncol; 2003 Mar; 82(3):209-16. PubMed ID: 12619066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
    Hughes TM; A'Hern RP; Thomas JM
    Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
    Kang JC; Wanek LA; Essner R; Faries MB; Foshag LJ; Morton DL
    J Clin Oncol; 2005 Jul; 23(21):4764-70. PubMed ID: 16034052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymphadenectomy for staging patients with intermediate-level melanoma.
    Smart KR; Cahoon BW; Dale PS
    Am Surg; 2000 Mar; 66(3):280-3. PubMed ID: 10759200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.